Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21372 | 421 | 42.2 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
103 | 3 | O GLCNACYLATION//O GLCNAC TRANSFERASE//O GLCNACASE | 73436 |
1698 | 2 | MUC1//MUCIN//MUC5AC | 6747 |
21372 | 1 | MUCUS PENETRATING PARTICLES//JOHNS HOPKINS ADULT CYST FIBROSIS PROGRAM//MUCUS BARRIER | 421 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MUCUS PENETRATING PARTICLES | authKW | 979141 | 4% | 75% | 18 |
2 | JOHNS HOPKINS ADULT CYST FIBROSIS PROGRAM | address | 323082 | 2% | 64% | 7 |
3 | MUCUS BARRIER | authKW | 222114 | 2% | 44% | 7 |
4 | BOVINE SUBMAXILLARY MUCIN BSM | authKW | 217589 | 1% | 100% | 3 |
5 | CANC NANOTECHNOL EXCELLENCE | address | 207734 | 3% | 22% | 13 |
6 | MULTIPLE PARTICLE TRACKING | authKW | 169227 | 2% | 33% | 7 |
7 | BIOSIMILAR MUCUS | authKW | 145059 | 0% | 100% | 2 |
8 | CONSIGLIO NAZL RIC IST NANOTECNOL CNR NANOTEC | address | 145059 | 0% | 100% | 2 |
9 | NPGM | authKW | 145059 | 0% | 100% | 2 |
10 | MUCUS | authKW | 120756 | 10% | 4% | 44 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1016 | 30% | 0% | 126 |
2 | Materials Science, Biomaterials | 739 | 7% | 0% | 30 |
3 | Chemistry, Multidisciplinary | 345 | 21% | 0% | 87 |
4 | Polymer Science | 277 | 11% | 0% | 45 |
5 | Biophysics | 262 | 10% | 0% | 42 |
6 | Nanoscience & Nanotechnology | 218 | 9% | 0% | 36 |
7 | Multidisciplinary Sciences | 163 | 4% | 0% | 15 |
8 | Chemistry, Physical | 153 | 15% | 0% | 65 |
9 | Engineering, Biomedical | 133 | 5% | 0% | 21 |
10 | Biochemistry & Molecular Biology | 65 | 15% | 0% | 62 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOHNS HOPKINS ADULT CYST FIBROSIS PROGRAM | 323082 | 2% | 64% | 7 |
2 | CANC NANOTECHNOL EXCELLENCE | 207734 | 3% | 22% | 13 |
3 | CONSIGLIO NAZL RIC IST NANOTECNOL CNR NANOTEC | 145059 | 0% | 100% | 2 |
4 | AUTOMOT DIGITAL TUNING | 72530 | 0% | 100% | 1 |
5 | CANC NANOTECHNOL EXCELLENCE NANOBIOTECHN | 72530 | 0% | 100% | 1 |
6 | CHEM BIOMOL ENGN JH PRIMARY POINMENT | 72530 | 0% | 100% | 1 |
7 | CHEM BIOMOL ENGN JH PRIMARY POINTMENT | 72530 | 0% | 100% | 1 |
8 | CHIM RICONSIMENTO MOL | 72530 | 0% | 100% | 1 |
9 | CONSUMER HEATLHCARE | 72530 | 0% | 100% | 1 |
10 | CONVERGENCE LASER AIDED INNOVAT MFG TEHNO | 72530 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOMACROMOLECULES | 6201 | 6% | 0% | 24 |
2 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 5637 | 4% | 0% | 17 |
3 | JOURNAL OF CONTROLLED RELEASE | 2799 | 4% | 0% | 17 |
4 | ADVANCED DRUG DELIVERY REVIEWS | 2700 | 2% | 0% | 10 |
5 | NANOMEDICINE | 2134 | 1% | 0% | 6 |
6 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1807 | 5% | 0% | 20 |
7 | MOLECULAR PHARMACEUTICS | 1118 | 2% | 0% | 7 |
8 | NANOTOXICOLOGY | 941 | 1% | 0% | 3 |
9 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 898 | 1% | 0% | 4 |
10 | BIOPHYSICAL JOURNAL | 816 | 4% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MUCUS PENETRATING PARTICLES | 979141 | 4% | 75% | 18 | Search MUCUS+PENETRATING+PARTICLES | Search MUCUS+PENETRATING+PARTICLES |
2 | MUCUS BARRIER | 222114 | 2% | 44% | 7 | Search MUCUS+BARRIER | Search MUCUS+BARRIER |
3 | BOVINE SUBMAXILLARY MUCIN BSM | 217589 | 1% | 100% | 3 | Search BOVINE+SUBMAXILLARY+MUCIN+BSM | Search BOVINE+SUBMAXILLARY+MUCIN+BSM |
4 | MULTIPLE PARTICLE TRACKING | 169227 | 2% | 33% | 7 | Search MULTIPLE+PARTICLE+TRACKING | Search MULTIPLE+PARTICLE+TRACKING |
5 | BIOSIMILAR MUCUS | 145059 | 0% | 100% | 2 | Search BIOSIMILAR+MUCUS | Search BIOSIMILAR+MUCUS |
6 | NPGM | 145059 | 0% | 100% | 2 | Search NPGM | Search NPGM |
7 | MUCUS | 120756 | 10% | 4% | 44 | Search MUCUS | Search MUCUS |
8 | MUCIN | 112577 | 15% | 2% | 64 | Search MUCIN | Search MUCIN |
9 | CYSTIC FIBROSIS SPUTUM | 96705 | 0% | 67% | 2 | Search CYSTIC+FIBROSIS+SPUTUM | Search CYSTIC+FIBROSIS+SPUTUM |
10 | HUMAN MUCUS | 96705 | 0% | 67% | 2 | Search HUMAN+MUCUS | Search HUMAN+MUCUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SIGURDSSON, HH , KIRCH, J , LEHR, CM , (2013) MUCUS AS A BARRIER TO LIPOPHILIC DRUGS.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 453. ISSUE 1. P. 56 -64 | 52 | 46% | 38 |
2 | BOEGH, M , NIELSEN, HM , (2015) MUCUS AS A BARRIER TO DRUG DELIVERY - UNDERSTANDING AND MIMICKING THE BARRIER PROPERTIES.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 116. ISSUE 3. P. 179 -186 | 28 | 65% | 11 |
3 | GRIESSINGER, J , DUNNHAUPT, S , CATTOZ, B , GRIFFITHS, P , OH, S , GOMEZ, SBI , WILCOX, M , PEARSON, J , GUMBLETON, M , ABDULKARIM, M , ET AL (2015) METHODS TO DETERMINE THE INTERACTIONS OF MICRO- AND NANOPARTICLES WITH MUCUS.EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. VOL. 96. ISSUE . P. 464 -476 | 35 | 47% | 5 |
4 | GROO, AC , LAGARCE, F , (2014) MUCUS MODELS TO EVALUATE NANOMEDICINES FOR DIFFUSION.DRUG DISCOVERY TODAY. VOL. 19. ISSUE 8. P. 1097 -1108 | 40 | 43% | 9 |
5 | SVENSSON, O , ARNEBRANT, T , (2010) MUCIN LAYERS AND MULTILAYERS - PHYSICOCHEMICAL PROPERTIES AND APPLICATIONS.CURRENT OPINION IN COLLOID & INTERFACE SCIENCE. VOL. 15. ISSUE 6. P. 395 -405 | 38 | 48% | 24 |
6 | SUK, JS , XU, QG , KIM, N , HANES, J , ENSIGN, LM , (2016) PEGYLATION AS A STRATEGY FOR IMPROVING NANOPARTICLE-BASED DRUG AND GENE DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 99. ISSUE . P. 28 -51 | 31 | 14% | 51 |
7 | MURGIA, X , PAWELZYK, P , SCHAEFER, UF , WAGNER, C , WILLENBACHER, N , LEHR, CM , (2016) SIZE-LIMITED PENETRATION OF NANOPARTICLES INTO PORCINE RESPIRATORY MUCUS AFTER AEROSOL DEPOSITION.BIOMACROMOLECULES. VOL. 17. ISSUE 4. P. 1536 -1542 | 16 | 70% | 2 |
8 | WANG, YY , LAI, SK , ENSIGN, LM , ZHONG, WX , CONE, R , HANES, J , (2013) THE MICROSTRUCTURE AND BULK RHEOLOGY OF HUMAN CERVICOVAGINAL MUCUS ARE REMARKABLY RESISTANT TO CHANGES IN PH.BIOMACROMOLECULES. VOL. 14. ISSUE 12. P. 4429-4435 | 25 | 52% | 7 |
9 | ABDULKARIM, M , AGULLO, N , CATTOZ, B , GRIFFITHS, P , BERNKOP-SCHNURCH, A , BORROS, S , GUMBLETON, M , (2015) NANOPARTICLE DIFFUSION WITHIN INTESTINAL MUCUS: THREE-DIMENSIONAL RESPONSE ANALYSIS DISSECTING THE IMPACT OF PARTICLE SURFACE CHARGE, SIZE AND HETEROGENEITY ACROSS POLYELECTROLYTE, PEGYLATED AND VIRAL PARTICLES.EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. VOL. 97. ISSUE . P. 230 -238 | 19 | 58% | 7 |
10 | DAS NEVES, J , ROCHA, CMR , GONCALVES, MP , CARRIER, RL , AMIJI, M , BAHIA, MF , SARMENTO, B , (2012) INTERACTIONS OF MICROBICIDE NANOPARTICLES WITH A SIMULATED VAGINAL FLUID.MOLECULAR PHARMACEUTICS. VOL. 9. ISSUE 11. P. 3347-3356 | 27 | 44% | 16 |
Classes with closest relation at Level 1 |